ATE427754T1 - Verwendung von il-17f zur behandlung und/oder pravention von neurologischen erkrankungen - Google Patents
Verwendung von il-17f zur behandlung und/oder pravention von neurologischen erkrankungenInfo
- Publication number
- ATE427754T1 ATE427754T1 AT05786995T AT05786995T ATE427754T1 AT E427754 T1 ATE427754 T1 AT E427754T1 AT 05786995 T AT05786995 T AT 05786995T AT 05786995 T AT05786995 T AT 05786995T AT E427754 T1 ATE427754 T1 AT E427754T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- treatment
- neurological diseases
- diseases
- neurological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04104573 | 2004-09-21 | ||
US63010504P | 2004-11-22 | 2004-11-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE427754T1 true ATE427754T1 (de) | 2009-04-15 |
Family
ID=36089871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05786995T ATE427754T1 (de) | 2004-09-21 | 2005-09-21 | Verwendung von il-17f zur behandlung und/oder pravention von neurologischen erkrankungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080286227A1 (de) |
EP (1) | EP1799248B1 (de) |
JP (1) | JP2008513415A (de) |
AT (1) | ATE427754T1 (de) |
AU (1) | AU2005286474A1 (de) |
CA (1) | CA2579166A1 (de) |
DE (1) | DE602005013805D1 (de) |
ES (1) | ES2324306T3 (de) |
IL (1) | IL181713A0 (de) |
NO (1) | NO20072048L (de) |
WO (1) | WO2006032673A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ595005A (en) * | 2009-04-01 | 2014-04-30 | Genentech Inc | Treatment of insulin-resistant disorders |
RU2460457C2 (ru) * | 2010-10-27 | 2012-09-10 | Общество с ограниченной ответственностью "Центр мануальной медицины" Академия вертебрологии "Радость движения" доктора А.Н. Сухоручко | Способ диагностики вертеброгенных болевых синдромов дегенеративно-дистрофических заболеваний позвоночника |
CN109659235B (zh) * | 2018-12-14 | 2021-12-03 | 武汉华星光电半导体显示技术有限公司 | Tft的制备方法、tft、阵列基板及显示装置 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6074849A (en) * | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
US20020177188A1 (en) * | 1998-05-15 | 2002-11-28 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US20020182673A1 (en) * | 1998-05-15 | 2002-12-05 | Genentech, Inc. | IL-17 homologous polypedies and therapeutic uses thereof |
ATE541930T1 (de) * | 1999-12-23 | 2012-02-15 | Genentech Inc | Il-17-homologe polypeptide und ihre therapeutische verwendung |
IL164214A0 (en) * | 2002-04-11 | 2005-12-18 | Zymogenetics Inc | Use of interleukin-24 to treat ovarian cancer |
-
2005
- 2005-09-21 DE DE602005013805T patent/DE602005013805D1/de active Active
- 2005-09-21 CA CA002579166A patent/CA2579166A1/en not_active Abandoned
- 2005-09-21 US US11/575,415 patent/US20080286227A1/en not_active Abandoned
- 2005-09-21 JP JP2007531766A patent/JP2008513415A/ja not_active Withdrawn
- 2005-09-21 WO PCT/EP2005/054719 patent/WO2006032673A1/en active Application Filing
- 2005-09-21 ES ES05786995T patent/ES2324306T3/es active Active
- 2005-09-21 AU AU2005286474A patent/AU2005286474A1/en not_active Abandoned
- 2005-09-21 AT AT05786995T patent/ATE427754T1/de not_active IP Right Cessation
- 2005-09-21 EP EP05786995A patent/EP1799248B1/de active Active
-
2007
- 2007-03-05 IL IL181713A patent/IL181713A0/en unknown
- 2007-04-20 NO NO20072048A patent/NO20072048L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20080286227A1 (en) | 2008-11-20 |
JP2008513415A (ja) | 2008-05-01 |
EP1799248A1 (de) | 2007-06-27 |
ES2324306T3 (es) | 2009-08-04 |
EP1799248B1 (de) | 2009-04-08 |
IL181713A0 (en) | 2008-03-20 |
CA2579166A1 (en) | 2006-03-30 |
AU2005286474A1 (en) | 2006-03-30 |
NO20072048L (no) | 2007-05-30 |
WO2006032673A1 (en) | 2006-03-30 |
DE602005013805D1 (de) | 2009-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301145I2 (nl) | Tirbanibulin | |
ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
ATE429645T1 (de) | Verwendung von eph-rezeptor-inhibitoren zur behandlung neurodegenerativer krankheiten | |
NO20054913L (no) | Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser | |
ATE512663T1 (de) | Kombination zur behandlung von erkrankungen mit zellproliferation | |
BRPI0517015A (pt) | compostos e composições como inibidores de atividade de receptor 1 de canabinóide | |
ATE456955T1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
ATE458485T1 (de) | Ubiquitin-ligase-hemmer und verwandte verfahren | |
ATE542535T1 (de) | Verwendung von azapaullonen zur vorbeugung und behandlung pankreatischer autoimmunkrankheiten | |
EA200801244A1 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
ATE338036T1 (de) | Zur behandlung hyperproliferativer erkrankungen geeignete benzofuran- und benzothiophenderivate | |
DE602005021766D1 (de) | Verfahren zur behandlung von atherosklerose | |
ATE423110T1 (de) | Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen | |
ATE427754T1 (de) | Verwendung von il-17f zur behandlung und/oder pravention von neurologischen erkrankungen | |
TW200716579A (en) | Novel chemical compounds | |
ATE494903T1 (de) | Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden | |
ATE426605T1 (de) | Inhibitoren von mitotischem kinesin | |
ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
DE502004012196D1 (de) | Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen | |
DE602004022423D1 (de) | Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz | |
ATE359088T1 (de) | Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten | |
DE502004011486D1 (de) | Antioxidationsmittel für organisches material und verfahren zur behandlung desselben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |